ArticleFood science & nutrition2026
Miao Sour Soup Modulates Hepatic Gluconeogenesis Through PI3K/Akt/Foxo1 Signaling in High-Fat Diet-Induced Rats.
Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Miao Sour Soup (MSS) is a traditional fermented dish containing bioactive constituents such as lycopene, capsaicin, and short-chain fatty acids, which have been associated with anti-obesity, anti-inflammatory, and antioxidant effects. Excessively elevated hepatic gluconeogenesis is a critical element instigating energy metabolism dysregulation in the body. This research examined the extent to which MSS enhances energy metabolism abnormalities caused by a high-fat diet via hepatic gluconeogenesis and confirmed this route. The findings indicated that MSS intervention markedly decreased hepatic lipid accumulation, pro-inflammatory cytokine secretion, and blood lipid and glucose levels in rats subjected to a high-fat diet. Non-targeted metabolomics study revealed that MSS influences energy metabolism pathways, including glycolysis and gluconeogenesis. Subsequently, Western blot analysis was conducted to assess protein expression in the NF-κB inflammatory pathway and the PI3K/Akt/Foxo1 signaling pathway. The findings indicated that MSS decreased NF-κB expression in the livers of rats subjected to a high-fat diet, thereby activating the PI3K/Akt/Foxo1 signaling pathway and decreasing the expression of PEPCK and G6PC, essential proteins in gluconeogenesis. This study's results demonstrate that Foxo1 is a crucial protein in the dysregulation of glucose metabolism caused by lipid metabolism diseases. MSS may stimulate the PI3K/Akt/Foxo1 signaling pathway by mitigating chronic inflammation caused by a high-fat diet, therefore inhibiting excessive hepatic gluconeogenesis and ultimately improving insulin resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.